Organon & (OGN) Wānana Kūʻai Kūʻai
Organ & Co.
Hōʻoia AI: OGN
Hoʻopuka ka AI i kahi kumukūʻai pahuhopu no ka lā kālepa aʻe, ka hopena pule a me ka hopena mahina. Hoʻomākaukau ʻia ka hoʻololi mai ka kumukūʻai hou loa. He helnau kūlana helu wale nō kēia, ʻaʻole he ʻōlelo aʻoaʻo hoʻopukapuka.
Kumukūʻai ma luna o nā mahina 6 i hala
Hōʻike ʻo Premium i nā pahuhopu kumukūʻai o ka AI no 1 lā, 1 pule a me 1 mahina no kēia a me nā stock ʻē aʻe.
Wehe iā Premium🔒 Moʻolelo hōʻike wānana
The forecast track record — every past forecast next to the actual close — is part of Premium.
Wehe iā PremiumE pili ana i kēia Hui
Organon & Co. is a global pharmaceutical company operating in the women’s health, biosimilars, and popular brands segments. The company develops contraceptives and fertility treatments, immunology products and oncology drugs, as well as a broad range of cardiovascular, respiratory, dermatological, and non-opioid therapy medications.
